The fructose nation

Journal of the American Society of Nephrology

Volumn 18, Issue 10, 2007, Pages 2619-2621

  Neilson, Eric G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCOSE; SUCROSE; SWEETENING AGENT;

EDITORIAL; FOOD INTAKE; GLUCOSE INTOLERANCE; HYPERTENSION; HYPOKALEMIA; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL;

EID: 34948866163     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007070750     Document Type: Editorial

References (28)

1. Bray GA, Nielsen SJ, Popkin BM: Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79: 537-543, 2004
2. Hallfrisch J: Metabolic effects of dietary fructose. FASEB J 4: 2652-2660, 1990
3. Nakagawa T, Tuttle KR, Short RA, Johnson RJ: Hypothesis: Fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1: 80-86, 2005
4. Corn Refiners Association: A brief history of the corn refining industry, Washington, DC, Corn Refiners Association, 2002. Available at: http://www.corn.org/web/history.htm. Accessed August 18, 2007.
5. Hanover LM, White JS: Manufacturing, composition, and applications of fructose. Am J Clin Nutr 58[Suppl]: 724S-732S, 1993
6. Putnam JJ: US food supply providing more food and calories. Food Rev 22: 2-12, 1999
7. Putnam JJ, Allshouse JE: Food Consumption, Prices, and Expenditures, 1970-1997. Bulletin #965. Washington, DC, US Department of Agriculture Economic Research Service, 1999
8. Huttunen JK: Fructose in medicine. A review with particular reference to diabetes mellitus. Postgrad Med J 47: 654-659, 1971
9. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25: 202-212, 2002
10. Satcher D: The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity, Washington, DC, Government Printing Office, Department of Health and Human Services, Public Health Service, 2001
11. Pollan M: You are what you grow, New York Times, 2007. Available at: http://www.nytimes.com/2007/04/22/magazine/22wwlnlede.t.html?pagewanted= 1&ei=5087%0A&em&en=5e517d47af28a63d&ex=1177905600
12. Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ: Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89: 2963-2972, 2004
13. Heinig M, Johnson RJ: Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73: 1059-1064, 2006
14. Zammit VA, Waterman IJ, Topping D, McKay G: Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr 131: 2074-2077, 2001
15. Kanabrocki EL, Third JL, Ryan MD, Nemchausky BA, Shirazi P, Scheving LE, McCormick JB, Hermida RC, Bremner WF, Hoppensteadt DA, Fareed J, Olwin JH: Orcadian relationship of serum uric acid and nitric oxide. JAMA 283: 2240-2241, 2000
16. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94: 2511-2515, 1994
17. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M: Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292; F423-F429, 2007
18. Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, Nakagawa T: Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol 18: 2724-2731, 2007
19. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP: LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315: 1278-1282, 2007
20. Rapoport MI, Hurd HF: Thiazide-induced glucose intolerance treated with potassium. Arch Intern Med 113: 405-408, 1964
21. Chazan JA, Boshell BR: Etiological factors in thiazide-induced or aggravated diabetes mellitus. Diabetes 14: 132-136, 1965
22. Ayvazian JH, Ayvazian LF: A study of the hyperuricemia induced by hydrochlorothiazide and acetazolamide separately and in combination. J Clin Invest 40: 1961-1966, 1961
23. Schiffman SS, Booth BJ, Losee ML, Pecore SD, Warwick ZS: Bitterness of sweeteners as a function of concentration. Brain Res Bull 36: 505-513, 1995
24. Schoenhals K: How sweet it is: Functional sweeteners. Natural Products Insider 2003. Available at: www.naturalproductsinside.com/articles/ 331FunctionalFood.html. Accessed August 18, 2007
25. Bellisle F, Drewnowski A: Intense sweeteners, energy intake and the control of body weight. Eur J Clin Nutr 61: 691-700, 2007
26. Drewnowski A, Darmon N: The economics of obesity: Dietary energy density and energy cost. Am J Clin Nutr 82: 265S-273S, 2005
27. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL: Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension 48: 219-224, 2006
28. Choi HK, Ford ES: Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 120: 442-447, 2007